Gossamer Bio Inc (GOSS)
Healthcare
Biotechnology
0.17 $
+2.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Gossamer Bio Inc (GOSS) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 07/29/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document → |
| 07/27/2026 | Current report (8-K) | Gossamer Bio, Inc. (GOSS): Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement; Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report → |
| 07/15/2026 | Current report (8-K) | Gossamer Bio, Inc. (GOSS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View report → |
Showing the 100 most recent filings of the selected type.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.